CIK 0001377121 · Large accelerated filer
Protagonist Therapeutics, Inc
Sign in to watch- Ticker
- PTGX
- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- FY end
- Dec 31
- Incorporated
- DE
- Entity type
- operating
- EIN
- 980505495
- Phone
- (510) 474-0170
- Business address
- 7707 GATEWAY BLVD., SUITE 140, NEWARK, CA, 94560-1160
- Former names
- Protagonist Therapeutics Inc, Protagonist Inc
- Open-market buys, last 90 days
- $0
- in 0 filings
- Open-market sales, last 90 days
- $26,552,861
- in 2 filings, $26.6M under 10b5-1 plans
Net −$26,552,861. Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.
Who's trading
90 days
| Date | Insider | Transaction | Shares | Price | Value | Owned after |
|---|---|---|---|---|---|---|
| 2024-01-02 | Giraudo Bryan Director | Grant or award · Stock Option (right to buy) | +25,700 | 25,700 | ||
| 2024-01-02 | MOLINA ARTURO MD Chief Medical Officer | Grant or award | +26,250 | 48,777 | ||
| 2024-01-02 | MOLINA ARTURO MD Chief Medical Officer | Grant or award · Stock Option (right to buy) | +97,500 | 97,500 | ||
| 2024-01-02 | Ali Asif Chief Financial Officer | Grant or award | +21,000 | 52,036 | ||
| 2024-01-02 | Ali Asif Chief Financial Officer | Grant or award · Stock Option (right to buy) | +78,000 | 78,000 | ||
| 2023-12-13 | PATEL DINESH V PH D President and CEO | Sale 10b5-1 | −75,000 | $20.08 | $1.5M | 534,347 |
| 2023-11-15 | MOLINA ARTURO MD Chief Medical Officer | Sale | −1,848 | $16.24 | $30K | 22,527 |
| 2023-10-26 | Swisher Daniel N JR Director | Grant or award · Stock Option (right to buy) | +45,000 | 45,000 | ||
| 2023-10-19 | Gupta Suneel Chief Development Officer | Option exercise | +20,000 | $7.38 | $148K | 168,317 |
| 2023-10-19 | Gupta Suneel Chief Development Officer | Option exercise · Stock Option (right to buy) | −20,000 | 50,000 | ||
| 2023-10-18 | PATEL DINESH V PH D President and CEO | Option exercise | +6,000 | $4.21 | $25K | 609,347 |
| 2023-10-18 | PATEL DINESH V PH D President and CEO | Option exercise · Stock Option (right to buy) | −6,000 | 54,000 | ||
| 2023-05-31 | Gupta Suneel Chief Development Officer | Grant or award | +12,000 | 152,187 | ||
| 2023-05-31 | Gupta Suneel Chief Development Officer | Shares withheld for taxes | −4,150 | $26.07 | $108K | 148,037 |
| 2023-05-31 | PATEL DINESH V PH D President and CEO | Grant or award | +30,000 | 615,111 | ||
| 2023-05-31 | PATEL DINESH V PH D President and CEO | Shares withheld for taxes | −12,165 | $26.07 | $317K | 602,946 |
| 2023-05-31 | Ali Asif Chief Financial Officer | Grant or award | +12,000 | 35,186 | ||
| 2023-05-31 | Ali Asif Chief Financial Officer | Shares withheld for taxes | −4,150 | $26.07 | $108K | 31,036 |
| 2023-04-18 | Ali Asif Chief Financial Officer | Shares withheld for taxes | −1,189 | $23.21 | $28K | 23,186 |
| 2023-04-10 | SELICK HAROLD E Director | Option exercise | +6,196 | $0.87 | $5K | 21,506 |
Page 14 of 29 · 580 trades